Inhibition of kinase IKKβ suppresses cellular abnormalities induced by the human papillomavirus oncoprotein HPV 18E6
Abstract Human papillomavirus (HPV) is the leading cause of cervical cancer and has been implicated in several other cancer types including vaginal, vulvar, penile, and oropharyngeal cancers. Despite the recent availability of a vaccine, there are still over 310,000 deaths each year worldwide. Curre...
Guardado en:
Autores principales: | Mojgan Padash Barmchi, Miranda Thomas, Jayashree V. Thatte, Arushi Vats, Bing Zhang, Ross L. Cagan, Lawrence Banks |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7444da68b90b44009b1780a02e5e7108 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus
por: Jiawei Zhao, et al.
Publicado: (2019) -
Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins
por: Mallory E. Harden, et al.
Publicado: (2017) -
An RNA aptamer provides a novel approach for the induction of apoptosis by targeting the HPV16 E7 oncoprotein.
por: Clare Nicol, et al.
Publicado: (2013) -
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody
por: Shiwen Peng, et al.
Publicado: (2021) -
Identification of human IKK-2 inhibitors of natural origin (part I): modeling of the IKK-2 kinase domain, virtual screening and activity assays.
por: Esther Sala, et al.
Publicado: (2011)